Search results
Teddi Mellencamp Thought She Was in Menopause but It Was 'Symptoms from the Copper IUD'
People Magazine· 4 days agoOn April 30, the Real Housewives of Beverly Hills alum posted a video on Instagram asking her...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 48 minutes agoTAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively ...
Red Cross to laud women from Chicago Heights, Dolton, who have made a habit of helping
Chicago Tribune· 14 hours agoBack when Chez Smith was an administrator at Cook County’s Fantus Clinic near Stroger Hospital in...
Paul F. deLespinasse: Supreme Court's Hobby Lobby decision was based on economic confusion
The Daily Telegram via Yahoo News· 4 days agoThe challenges to the contraception requirement in the Affordable Care Act — Obamacare — were based...
Opinion | Where’s Josh Shapiro’s Pragmatism When You Need It?
The Wall Street Journal· 8 hours agoIt was nowhere to be found in his treatment of the Little Sisters of the Poor.
After Roe, an Abortion 'Underground' Emerges
newser· 1 day ago"This is the underground," said Jerad Martindale, an activist in Boise. Abortion rights advocates worry Idaho is a harbinger of where more states may be...
After Roe, the network of people who help others get abortions see themselves as ‘the underground’
FOX 4 Kansas City· 1 day agoNAMPA, Idaho (AP) — Waiting in a long post office line with the latest shipment of “abortion...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
WTNH-TV New Haven· 2 days agoFollowing RP, patients who received the treatment regimen showed a 100% biochemical recurrence...
Cwm LLC Acquires 1,087 Shares of Organon & Co. (NYSE:OGN)
ETF DAILY NEWS· 19 hours agoCwm LLC raised its holdings in shares of Organon & Co. (NYSE:OGN – Free Report) by 8.3% in the fourth quarter, according to the company in its most recent Form 13F filing ...
...Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-...
The Tomahawk· 4 days agoA comment in the same issue discussed implications of the data and recognized microarray technology for its potential to be "game-changing in humanitarian settings." In the same issue, the needle ...